ArticleBiochemistry and biophysics reports2026
A simple and rapid method for generating antibodies against bovine alphaherpesvirus 1 viral proteins through immunization with virus-infected murine cells.
Article in Biochemistry and biophysics reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Bovine alphaherpesvirus 1 (BoAHV-1) infects cattle and typically results in significant economic losses for the cattle industry worldwide. Currently, antibodies targeting only a limited number of viral proteins are commercially available. It has been reported that BoAHV-1 is capable of infecting numerous tumor cell lines. Based on the rationale of immune tolerance, we hypothesized that virus-infected murine cells could be directly used to immunize mice, thereby generating antibodies against viral proteins. In this study, we found that BoAHV-1 can infect murine cell lines including LA795 and MC38, as determined using both Western blot and immunofluorescence analyses. Immunizing mice with virus-infected cells, either through subcutaneous or intraperitoneal injection, stimulates the production of high levels of antibodies that specifically recognize the viral proteins synthesized in bovine kidney (MDBK) cells, as characterized by both Western blot and/or immunofluorescence. Furthermore, our findings suggest that intraperitoneal immunization could more effectively elicit antibodies against a wider array of viral proteins. As a homemade antibody generation method, this approach bypasses the complex and time-consuming steps of producing and purifying recombinant proteins as antigen, which are typically performed in conventional methods for antibody generation. Thus, we present a simple, rapid, and cost-effective method for generating virus-specific antibodies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.